Morgan Stanley Reiterates Equal-Weight on Merck & Co, Maintains $109 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has reiterated an Equal-Weight rating on Merck & Co (NYSE:MRK) and maintained a price target of $109.
July 11, 2023 | 1:29 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley has reiterated an Equal-Weight rating on Merck & Co and maintained a price target of $109.
The reiteration of the Equal-Weight rating and price target by Morgan Stanley indicates that the analyst sees the stock as fairly valued at the current price. This is likely to have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100